100 related articles for article (PubMed ID: 15969858)
1. Improvements in quality of life associated with epoetin alfa treatment are clinically, as well as statistically, significant.
Curr Med Res Opin; 2005; 21 Suppl 2():S3-5. PubMed ID: 15969858
[TBL] [Abstract][Full Text] [Related]
2. Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy.
Curr Med Res Opin; 2005; 21 Suppl 2():S9-11. PubMed ID: 15969860
[TBL] [Abstract][Full Text] [Related]
3. Epoetin alfa offers clinically significant improvements in the quality of life of anaemic cancer patients.
Curr Med Res Opin; 2005; 21 Suppl 2():S12-5. PubMed ID: 15969861
[TBL] [Abstract][Full Text] [Related]
4. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
[TBL] [Abstract][Full Text] [Related]
5. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
6. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
[TBL] [Abstract][Full Text] [Related]
7. Benefits of epoetin alfa for cancer patients' quality of life are confirmed after modelling to account for missing data.
Curr Med Res Opin; 2005; 21 Suppl 2():S6-8. PubMed ID: 15969859
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the effects of epoetin alfa treatment on quality of life in anaemic cancer patients.
Curr Med Res Opin; 2005; 21 Suppl 2():S16-8. PubMed ID: 15969862
[TBL] [Abstract][Full Text] [Related]
9. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.
Chu E; Einhorn LH; Lefebvre P
J Support Oncol; 2006 May; 4(5):243-50. PubMed ID: 16724648
[TBL] [Abstract][Full Text] [Related]
11. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
Crawford J; Cella D; Cleeland CS; Cremieux PY; Demetri GD; Sarokhan BJ; Slavin MB; Glaspy JA
Cancer; 2002 Aug; 95(4):888-95. PubMed ID: 12209734
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
13. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
[TBL] [Abstract][Full Text] [Related]
14. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
[TBL] [Abstract][Full Text] [Related]
15. Increased hemoglobin levels and improved quality-of-life assessments during epoetin alfa treatment in anemic cancer patients: results of a prospective, multicenter German trial.
Reinhardt U; Tulusan A; Angermund R; Lutz H;
Oncologist; 2005 Mar; 10(3):225-37. PubMed ID: 15793226
[TBL] [Abstract][Full Text] [Related]
16. Impact of epoetin alfa in chemotherapy-associated anemia.
Jilani SM; Glaspy JA
Semin Oncol; 1998 Oct; 25(5):571-6. PubMed ID: 9783596
[TBL] [Abstract][Full Text] [Related]
17. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
18. Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy.
Iconomou G; Koutras A; Karaivazoglou K; Kalliolias GD; Assimakopoulos K; Argyriou AA; Ifanti A; Kalofonos HP
Eur J Cancer Care (Engl); 2008 Nov; 17(6):535-41. PubMed ID: 18707621
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.
Mystakidou K; Kalaidopoulou O; Katsouda E; Parpa E; Kouskouni E; Chondros C; Tsiatas ML; Vlahos L
Anticancer Res; 2005; 25(5):3495-500. PubMed ID: 16101168
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.
Razzouk BI; Hord JD; Hockenberry M; Hinds PS; Feusner J; Williams D; Rackoff WR
J Clin Oncol; 2006 Aug; 24(22):3583-9. PubMed ID: 16877725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]